Foghorn Therapeutics Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of FHTX for the last quarter is 5.77 M USD, and it's 66.99% lower compared to the previous quarter. The net income of Q4 23 is -24.11 M USD.